WENA: Rasio kapitalisasi marang pendapatan anewmeds.com
Anew Medical, Inc. (WENA) is optimizing expenses by outsourcing vector production, while its unique patents protect the company from pricing pressure. The P/S multiple chart allows for the determination of fair valuation ranges, where the 0.00 indicator expresses the state of the metric. Anew Medical, Inc. (WENA) aims to halt neurodegeneration by creating innovative gene therapies to combat Parkinson's and Alzheimer's diseases.
Rincian metrik lan analitis perusahaan Anew Medical, Inc. (WENA)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Anew Medical, Inc.|WENA - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas anewmeds.com|WENA - Gunggung utang perusahaan|Rasio utang marang aset resik Anew Medical|WENA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Anew Medical|Rasio likuiditas darurat anewmeds.com
- data bathi resik lan rasio valuasi:
WENA - Bathi resik|Bathi mangsa ngarep Anew Medical, Inc.|WENA - Koefisien rega marang bathi|Kapitalisasi marang proyeksi bathi Anew Medical Inc.|WENA - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Anew Medical|WENA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Anew Medical|WENA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan anewmeds.com|WENA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Anew Medical, Inc.
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:Anew Medical Inc., WENA
The specifics of developing neurological disease therapies amidst geopolitical instability and logistical disruptions make Anew Medical, Inc. (WENA) revenue a key indicator of viability. By analyzing the price-to-sales ratio, an investor assesses the business's market value relative to sales volumes, which allows for determining the extent of overpayment for the asset or identifying the company's undervaluation across different phases of the economic cycle.
Perusahaan pesaing
BIIB - Rega marang dodolan|Multiplikator P/S NBIX (Neurocrine Biosciences, Inc.)|RGC: Rasio kapitalisasi marang pendapatan|Axsome Therapeutics Inc - Multiplikator P/S|Koefisien rega marang pendapatan ACADIA Corp ACAD|XENE: Multiplikator P/S|Kapitalisasi marang pendapatan vikingtherapeutics.com|SUPN (Supernus) - Multiplikator P/S|Multiplikator P/S Catalyst Pharma|Rasio rega marang pendapatan Denali Therapeutics Inc (DNLI)|Rasio rega marang pendapatan HRMY (Harmony Corp)|Biohaven Ltd. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan AMLX|Trevi Therapeutics, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan Praxis Precision Medicines Inc PRAX|Anavex Corp (AVXL) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan CBLL|PRTA (Prothena Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Alector Therapeutics (ALEC)|Kapitalisasi marang pendapatan ANNX (Annexon)|Koefisien rega marang pendapatan omeros.com|Neurogene Corp - Kapitalisasi marang pendapatan|ACIU - Kapitalisasi marang pendapatan|Voyager Therapeutics - Multiplikator P/S|Rega marang dodolan neumoratx.com|Scilex (SCLX) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan TVGN|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Multiplikator P/S Cognition Therapeutics Inc.|Rasio rega marang pendapatan Inhibikase Therapeutics (IKT)|cassavasciences.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ASRT (Assertio)|Coya Therapeutics Inc (COYA) - Rega marang dodolan|VTGN: Kapitalisasi marang pendapatan|OVID - Multiplikator P/S|Acumen Pharmaceuticals (ABOS) - Rasio rega marang pendapatan|cervomed.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Ltd.|Rega marang dodolan Clene Nanomedicine CLNN|Multiplikator P/S PEPG|Multiplikator P/S Jupiter Neurosciences, Inc. (JUNS)|Rasio rega marang pendapatan Relmada Therapeutics RLMD|ANVS: Rasio kapitalisasi marang pendapatan|Grace Tx - Multiplikator P/S|Rega marang dodolan Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Kapitalisasi marang pendapatan|Kapitalisasi marang pendapatan NeuroSense Therapeutics Ltd.|Kapitalisasi marang pendapatan RVPH|MTVA: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan NeurAxis (NRXS)|Kapitalisasi marang pendapatan heliusmedical.com HSDT|Multiplikator P/S PASG (Passage Bio)|Neuphoria Therapeutics, Inc. (NEUP) - Rega marang dodolan|Minerva Neurosciences - Multiplikator P/S|ATHA (athira.com) - Rasio kapitalisasi marang pendapatan|ADXN: Multiplikator P/S|ALZN - Koefisien rega marang pendapatan|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Protagenic (PTIX)|Multiplikator P/S KTTA|Multiplikator P/S cortigent.com (CRGT)|Rasio rega marang pendapatan Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. - Rasio rega marang pendapatan|CARA: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CHRO (Chromocell)|ELYM: Multiplikator P/S|ITCI - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Longboard Pharmaceuticals, Inc.|Rasio kapitalisasi marang pendapatan MRNS (Marinus Pharmaceuticals Inc)|Multiplikator P/S NKGN|Kapitalisasi marang pendapatan NeuroBo Pharma NRBO|Sage Therapeutics, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan synaptogen.com (SNPX)|TRVN: Kapitalisasi marang pendapatan|Vigil Neuroscience (VIGL) - Kapitalisasi marang pendapatan|CERE: Multiplikator P/S
